2-[2-(4-氟苯基)-2-酮代-1-苯基-d5-乙基]-4-甲基-3-酮代戊酸, (2-苄氧基苯基)-酰胺
2-[2-(4-氟苯基)-2-酮代-1-苯基-d5-乙基]-4-甲基-3-酮代戊酸, (2-苄氧基苯基)-酰胺
阿托伐他汀代谢物中间体内标物;2-[2-(4-氟苯基)-2-酮代-1-苯基-d5-乙基]-4-甲基-3-酮代戊酸, (2-苄氧基苯基)-酰胺
2-[2-(4-Fluorophenyl)-2-oxo-1-phenyl-d5-ethyl]-4-methyl-3-oxo-pentanoic Acid, (2-Benzyloxy-phenyl)-amide
阿托伐他汀代谢物中间体内标物;2-[2-(4-氟苯基)-2-酮代-1-苯基-d5-乙基]-4-甲基-3-酮代戊酸, (2-苄氧基苯基)-酰胺
2-[2-(4-Fluorophenyl)-2-oxo-1-phenyl-d5-ethyl]-4-methyl-3-oxo-pentanoic Acid, (2-Benzyloxy-phenyl)-amide
-
产品编号: CFR595736
-
CAS号: 1020719-43-0
-
相关CAS号:887355-33-1(未标记)
-
分子式:C33H25D5FNO4
-
分子量:528.62
英文别名:
-
可溶性:
Acetone, Chloroform, Dichloromethane, Ethyl Acetate
性状:
Light Yellow Foamy Solid
SMILES:
BrC1=CC=C2C(COC2C2C=CC(F)=CC=2)=C1
A deuterated intermediate of the metabolite of Atorvastin, a selective, competitive HMG-CoA reductase inhibitor. Atorvastin is the only drug in its class specfically indicated for lowering both elevated LDL-cholesterol and triglycerides in patients with hypercholesterolemia.
搜索质检报告(COA)
搜索MSDS